High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
Open Access
- 11 August 2015
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 12991
Abstract
RTK-like orphan receptor 2 (ROR2) is overexpressed in several cancers and has tumorigenic activity. However, the expression of ROR2 and its functional and prognostic significance have yet to be evaluated in pancreatic ductal adenocarcinoma (PDAC). Quantitative real-time polymerase chain reaction was used to characterize the expression of ROR2 mRNA in PDAC, corresponding peritumoral tissues and PDAC cell lines. Immunohistochemical analysis with tissue microarrays was used to evaluate ROR2 expression in PDAC and to investigate the relationship of this expression to clinicopathological factors and prognosis. The expression of ROR2 mRNA and protein was significantly higher in PDAC than in normal pancreatic tissues. High cytoplasmic ROR2 expression in cancer cells was significantly associated with a primary tumor, distant metastasis and TNM stage and high stromal ROR2 expression was significantly associated with regional lymph node metastasis and TNM stage. The Kaplan–Meier method and Cox regression analyses showed that high ROR2 expression in tumor cytoplasm or stromal cells was significantly associated with malignant attributes and reduced survival in PDAC. We present strong evidence that ROR2 could be used as an indicator of poor prognosis and could represent a novel therapeutic target for PDAC.Keywords
This publication has 47 references indexed in Scilit:
- External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer PatientsPLOS ONE, 2013
- MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3PLOS ONE, 2013
- A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP studyBritish Journal of Cancer, 2012
- Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptorsGenes & Development, 2010
- Identification of Ror2 as a Hypoxia-inducible Factor Target in von Hippel-Lindau-associated Renal Cell CarcinomaJournal of Biological Chemistry, 2010
- The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanomaOncogene, 2009
- A Wnt Survival Guide: From Flies to Human DiseaseJournal of Investigative Dermatology, 2009
- Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinomaOncogene, 2009
- Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migrationJournal of Cell Biology, 2006
- The discovery of receptor tyrosine kinases: targets for cancer therapyNature Reviews Cancer, 2004